You are here


PremieBreathe is a low-cost breathing aid for newborns designed to treat pneumonia and other respiratory illnesses, which cause over 1 million preventable deaths each year due to a lack of affordable care. PremieBreathe’s humidified high flow nasal cannula system provides reliable, safe breathing support with minimal need for additional clinical infrastructure - making PremieBreathe ideally designed for low-resource hospitals in the developing world.

TEAM: Katy Chan (YC ’15), Shirin Ahmed (YC ’12), Charles Stone (YC ’14), Jordan Sabin (YC ’16), David Wang (YC ’18)